Our ambition with the SIRIC program is to connect multidisciplinary research with state of the art medical care to solve the question of resistance to anti-cancer treatment.
SIRIC is a national translational research label awarded by the French National Cancer Institute (INCa) as part of the Cancer Plan. Institut Curie was labeled in both 2011 and 2018.
SIRICs are multidisciplinary research sites where different research dimensions are united (fundamental, clinical, public health, epidemiology, human and social sciences) and where the critical mass of doctors, patients, researchers, are committed to the constraints – notably competitiveness and quality – of translational research.
